Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,61 USD | +2,90% | +0,44% | -11,85% |
11/03 | Sectorupdate: Aandelen gezondheidszorg eind van de middag zachter | MT |
11/03 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2021 | 172 mln. 161 mln. | Omzet 2022 | 317 mln. 297 mln. | Marktkapitalisatie | 380 mln. 357 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -8 mln. -7,51 mln. | Nettowinst (verlies) 2022 | 35 mln. 32,86 mln. | EV/omzet 2021 | 3,44 x |
Nettoliquiditeiten 2021 | 67,84 mln. 63,68 mln. | Nettoschuld 2022 | 10,19 mln. 9,56 mln. | EV/omzet 2022 | 1,23 x |
K/w-verhouding 2021 |
-77
x | K/w-verhouding 2022 |
10,7
x | Werknemers | 134 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 65,14% |
Recentste transcriptie over Eagle Pharmaceuticals, Inc.
1 dag | +2,90% | ||
1 week | +0,44% | ||
Lopende maand | -12,02% | ||
1 maand | -16,18% | ||
3 maanden | +2,90% | ||
6 maanden | -65,57% | ||
Lopend jaar | -11,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Graves
CEO | Chief Executive Officer | 61 | 01-11-13 |
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Ryan Debski
CMP | Compliance Officer | - | 01-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven B. Ratoff
DFI | Director of Finance/CFO | 81 | 01-03-07 |
Jennifer Simpson
BRD | Director/Board Member | 55 | 28-08-19 |
Richard Edlin
BRD | Director/Board Member | 63 | 17-03-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.54% | 29 M€ | -5,60% | ||
0.25% | 27 M€ | -5,75% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 4,61 | +2,90% | 59 516 |
18-04-24 | 4,48 | +2,05% | 135 741 |
17-04-24 | 4,39 | -6,40% | 109 204 |
16-04-24 | 4,69 | -9,81% | 161 336 |
15-04-24 | 5,2 | +13,29% | 381 329 |
uitgestelde koers Nasdaq, 19 april 2024 om 22:00 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-11,85% | 58,18 mln. | |
+10,08% | 9,12 mld. | |
-17,63% | 4,8 mld. | |
+0,73% | 3,8 mld. | |
+16,55% | 3,72 mld. | |
+27,76% | 2,58 mld. | |
-26,11% | 2,36 mld. | |
-30,09% | 2,11 mld. | |
+7,15% | 1,86 mld. | |
-0,50% | 1,64 mld. |